ProQR Therapeutics (PRQR) Revenue Growth (3y) (2015 - 2026)
ProQR Therapeutics (PRQR) Revenue Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | ProQR Therapeutics | 185.44 Mn | 93.15 Mn | - | 45.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.87% |
| Dec 31, 2025 | 86.73% |
| Sep 30, 2025 | 52.41% |
| Jun 30, 2025 | 60.11% |
| Mar 31, 2025 | 58.73% |
| Dec 31, 2024 | 162.18% |
| Sep 30, 2024 | 63.95% |
| Jun 30, 2024 | 196.05% |
| Mar 31, 2024 | -28.36% |
| Dec 31, 2023 | -34.46% |
| Sep 30, 2023 | -49.85% |
| Jun 30, 2023 | -28.95% |
| Mar 31, 2023 | -65.87% |
| Dec 31, 2022 | -65.43% |
| Sep 30, 2022 | -60.74% |
| Jun 30, 2022 | -57.17% |
| Mar 31, 2022 | -57.52% |
| Dec 31, 2021 | -73.50% |
| Sep 30, 2021 | -51.20% |
| Jun 30, 2021 | -70.76% |